To overcome these issues, Islam et al.119 used polymer-lipid hybrid nanoparticles for the systemic delivery of modified PTEN mRNA to tumor cells, which effectively overcame several potential challenges in mRNA delivery, including large size, high negative charge, easy degradation, and poor protein translation. This evidence concerns the gene PTEN and neoplasm.